Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -9.96x is 69% above its 4-year average of -32.01x, near the high end of its 4-year range (-3231.85x–-9.96x).
As of the fiscal period ended Saturday, December 31, 2022. 93.31% above its 12-month average of -148.77x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2022 (2022-12-31): -9.96x.
INTEREST COVERAGE RATIO
-9.96x
INTEREST COVERAGE RATIO AVG TTM
-148.77x
INTEREST COVERAGE RATIO AVG 3Y
-32.97x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+93.31%
CURRENT VS 3Y AVG
+69.79%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.49x
median of 379 covered companies
CURRENT VS SECTOR MEDIAN
-121.82%
vs the sector median at left
Compass Therapeutics, Inc.
Market Cap
$171.37M
Interest Coverage Ratio
-9.96x
TTM Avg
-148.77x
3Y Avg
-32.97x
5Y Avg
N/A
Market Cap
$170.79M
Interest Coverage Ratio
-74.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.75M
Interest Coverage Ratio
-36.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.33M
Interest Coverage Ratio
-38.13x
TTM Avg
21.71x
3Y Avg
21.71x
5Y Avg
21.71x
Market Cap
$165.32M
Interest Coverage Ratio
-19.95x
TTM Avg
6.75x
3Y Avg
6.75x
5Y Avg
6.75x
Market Cap
$178.15M
Interest Coverage Ratio
-709.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$179.99M
Interest Coverage Ratio
-2.21x
TTM Avg
15.94x
3Y Avg
15.94x
5Y Avg
15.94x
Market Cap
$157.44M
Interest Coverage Ratio
N/A
TTM Avg
2247.41x
3Y Avg
1131.54x
5Y Avg
905.57x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | $171.37M | -9.96x | -148.77x | -32.97x | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $170.79M | -74.29x | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX)vs › | $170.64M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $169.75M | -36.67x | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $172.33M | -38.13x | 21.71x | 21.71x | 21.71x |
| Coherus Oncology, Inc. (CHRS)vs › | $165.32M | -19.95x | 6.75x | 6.75x | 6.75x |
| Canton Strategic Holdings Inc (CNTN)vs › | $178.15M | -709.33x | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $179.99M | -2.21x | 15.94x | 15.94x | 15.94x |
| Inogen, Inc. (INGN)vs › | $157.44M | N/A | 2247.41x | 1131.54x | 905.57x |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | -1.03x | N/A | N/A | N/A |
Interest Coverage
-10.0x
Debt/Equity
0.06
Current Ratio
11.22
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-12-31 | -9.96x |
| 2022-09-30 | -20.22x |
| 2022-06-30 | -21.20x |
| 2022-03-31 | -359.10x |
| 2021-12-31 | -333.36x |
| 2021-09-30 | -75.05x |
| 2021-06-30 | -501.70x |
| 2021-03-31 | -51.68x |
| 2020-12-31 | -44.66x |
| 2020-09-30 | -42.27x |
| 2020-06-30 | -20.95x |
| 2020-03-31 | -21.13x |
| 2019-12-31 | -22.54x |
| 2019-09-30 | -26.87x |
| 2019-06-30 | -27.62x |
| 2019-03-31 | -3231.85x |
